Nupharm Llc - Net Worth and Insider Trading

Nupharm Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nupharm Llc owns 1 companies in total, including Emmaus Life Sciences Inc (EMMA) .

Click here to see the complete history of Nupharm Llc’s form 4 insider trades.

Insider Ownership Summary of Nupharm Llc

Ticker	Comapny	Transaction Date	Type of Owner
EMMA	Emmaus Life Sciences Inc	2007-03-07	10 percent owner

Nupharm Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nupharm Llc Ownership Network

Ownership Network List of Nupharm Llc

No Data

Ownership Network Relation of Nupharm Llc

Nupharm Llc Owned Company Details

What does Emmaus Life Sciences Inc do?

Who are the key executives at Emmaus Life Sciences Inc?

Nupharm Llc is the 10 percent owner of Emmaus Life Sciences Inc. Other key executives at Emmaus Life Sciences Inc include director & Vice Chairman & COO Willis C Lee , director & 10 percent owner & Chairman and CEO Yutaka Niihara , and CIO & SVP George Sekulich .

Emmaus Life Sciences Inc (EMMA) Insider Trades Summary

Over the past 18 months, Nupharm Llc made no insider transaction in Emmaus Life Sciences Inc (EMMA). Other recent insider transactions involving Emmaus Life Sciences Inc (EMMA) include a net purchase of 120,700 shares made by Seah H. Lim , and a net purchase of 251,809 shares made by Willis C Lee .

In summary, during the past 3 months, insiders sold 0 shares of Emmaus Life Sciences Inc (EMMA) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 38,500 shares of Emmaus Life Sciences Inc (EMMA) were sold and 411,009 shares were bought by its insiders, resulting in a net purchase of 372,509 shares.

Emmaus Life Sciences Inc (EMMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Emmaus Life Sciences Inc Insider Transactions

No Available Data

Nupharm Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Nupharm Llc. You might contact Nupharm Llc via mailing address: 13151 Chandler Boulevard, Sherman Oaks Ca 91401.

Discussions on Nupharm Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.